Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hemant Surgical IndustriesBOM:543916 -0.87%80 Days Payable is 65.43 as of Mar. 2026, which is 23% below its 10-year median of 85.41. GuruFocus rates BOM:543916 with a GF Score™ of 80/100 and a GF Value™ of ₹332.62 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 794 Medical Devices & Instruments companies, Hemant Surgical Industries ranks better than 61.21% on this metric.
The historical rank and industry rank for Hemant Surgical Industries's Days Payable or its related term are showing as below:
BOM:543916'
s Days Payable Range Over the Past 10 Years
Min: 10.54 Med: 85.41 Max: 153.29
Current: 91.12
During the past 6 years, Hemant Surgical Industries's highest Days Payable was 153.29. The lowest was 10.54. And the median was 85.41.
BOM:543916's Days Payable is ranked better than 61.21% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 67.85
vs BOM:543916: 91.12
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543916 vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Hemant Surgical Industries's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hemant Surgical Industries Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hemant Surgical Industries's Days Payable distribution charts can be found below:
* The bar in red indicates where Hemant Surgical Industries's Days Payable falls into.
Hemant Surgical Industries Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hemant Surgical Industries (BOM:543916) has a Days Payable of 65.43 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Hemant Surgical Industries and its competitors. This is 23% below median its historical median of 85.41. Over the past decade, Hemant Surgical Industries' Days Payable has ranged from 10.54 to 153.29. According to the industry distribution chart, Hemant Surgical Industries ranks #308 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 38.8%.
Is Hemant Surgical Industries' Days Payable too high?
Hemant Surgical Industries' current Days Payable of 65.43 is 23% below median its 10-year median of 85.41. Over the past 10 years, this metric has ranged from a low of 10.54 to a high of 153.29. The Medical Devices & Instruments industry median Days Payable is 67.85. Hemant Surgical Industries' value of 65.43 is 3.6% below this industry median. Based on the distribution chart, Hemant Surgical Industries ranks #308 out of 794 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Hemant Surgical Industries has a GF Score™ of 80/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hemant Surgical Industries' Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Hemant Surgical Industries ranks #308 out of 794 companies for Days Payable. This puts Hemant Surgical Industries in the upper half of its industry. The industry median Days Payable is 67.85. Hemant Surgical Industries' value of 65.43 is 3.6% below this benchmark. Historically, Hemant Surgical Industries' own Days Payable has ranged from 10.54 to 153.29 over the past decade. While the company's 10-year median is 85.41 vs. the industry median of 67.85, Hemant Surgical Industries has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.85, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hemant Surgical Industries's current Days Payable of 65.43 is 3.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Hemant Surgical Industries and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hemant Surgical Industries's current Days Payable is 65.43, which is 23% below median its own 10-year median of 85.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hemant Surgical Industries stock overvalued right now?
Based on GuruFocus' analysis, Hemant Surgical Industries (BOM:543916) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹332.62, compared to a current price of ₹380.90 — trading 14.5% above its estimated fair value. The current Days Payable is 65.43, which is 23% below median its 10-year median of 85.41 and 3.6% below the Medical Devices & Instruments industry median of 67.85. Hemant Surgical Industries' overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Hemant Surgical Industries (BOM:543916), the current Days Payable is 65.43 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hemant Surgical Industries (BOM:543916) Overvalued in 2026?
Based on GuruFocus' analysis, Hemant Surgical Industries stock appears to be overvalued.
The current stock price of ₹380.90 is trading 14.5% above its estimated GF Value™ of ₹332.62.
GuruFocus considers Hemant Surgical Industries to be Modestly Overvalued.
Key valuation signals for BOM:543916:
Days Payable: 65.43 (23% below median its 10-year median of 85.41)
GF Value™: ₹332.62 vs. price of ₹380.90 (14.5% above fair value)
Industry Position: 3.6% below the Medical Devices & Instruments median (#308 of 794)
No single metric tells the full story. See the BOM:543916 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hemant Surgical Industries Ltd is engaged in Importing, manufacturing, and marketing quality surgical and Pharmaceutical Products at an economical price. Its product offerings cover a wide spectrum of equipment and disposables required for (i) Renal Care, (ii) Cardiovascular Disease, (iii) Respiratory Disease, (iv) Critical Care and Radiology, and (v) Surgical disposables. Its products include JMS Meditape, JMS Infusion Set, JMS Scalp Vein Set, Ventilators, ECG Machines, and others.
80GF Score
Get the complete analysis for BOM:543916
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543916 has been successfully added to your 
